Table III.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Parameters | Hazard Ratio | 95% CI (lower-upper) | P-value | Hazard Ratio | 95% CI (lower-upper) | P-value |
Age | 1.02 | 0.7–1.48 | 0.926 | |||
Sex | 0.82 | 0.57–1.16 | 0.263 | |||
Histological type | 0.98 | 0.27–3.63 | 0.982 | |||
Histologic grade | 1.05 | 0.85–1.31 | 0.651 | |||
Stage | 1.38 | 1.15–1.65 | 0.001 | 0.85 | 0.69–1.06 | 0.151 |
T classification | 1.65 | 1.38–1.98 | 0.000 | 1.83 | 1.46–2.3 | 0.000 |
N classification | 0.71 | 0.5–1.03 | 0.071 | |||
M classification | 0.70 | 0.48–1.02 | 0.061 | |||
Radiation therapy | 0.52 | 0.26–1.03 | 0.061 | |||
Residual tumor | 1.42 | 1.12–1.79 | 0.004 | 1.43 | 1.12–1.83 | 0.004 |
BACE1-AS1 | 1.81 | 1.28–2.56 | 0.001 | 1.76 | 1.24–2.49 | 0.001 |
BACE1-AS, β-site APP-cleaving enzyme 1 antisense.